<DOC>
	<DOCNO>NCT01243671</DOCNO>
	<brief_summary>To investigate efficacy , safety pharmacokinetics adalimumab subcutaneous ( sc ) Japanese subject intestinal Behçet 's disease refractory conventional therapy .</brief_summary>
	<brief_title>A Study Adalimumab Japanese Subjects With Intestinal Behçet 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Behcet Syndrome</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Intestinal Behçet 's disease Patients typical ulcer ileocecal region Patients fail conventional treatment Crohn 's disease History ileocecal resection History tuberculosis ( TB ) Female subject pregnant breastfeeding consider become pregnant study</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Behçet 's , intestinal</keyword>
</DOC>